Multiple system atrophy treatment Fundamentals Explained
on the other hand, procedural linked adverse events (compact ischemic Mind lesions on intra-arterial infusion) lifted protection fears. This has prompted the conduct of A different phase I trial revisiting the protection and tolerability of intra-arterial (carotid arteries) injection of autologous bone marrow-derived mesenchymal stem cells in MSA-C